These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
249 related items for PubMed ID: 26047923
1. The Docosanoid Neuroprotectin D1 Induces TH-Positive Neuronal Survival in a Cellular Model of Parkinson's Disease. Calandria JM, Sharp MW, Bazan NG. Cell Mol Neurobiol; 2015 Nov; 35(8):1127-36. PubMed ID: 26047923 [Abstract] [Full Text] [Related]
2. PYM50028, a novel, orally active, nonpeptide neurotrophic factor inducer, prevents and reverses neuronal damage induced by MPP+ in mesencephalic neurons and by MPTP in a mouse model of Parkinson's disease. Visanji NP, Orsi A, Johnston TH, Howson PA, Dixon K, Callizot N, Brotchie JM, Rees DD. FASEB J; 2008 Jul; 22(7):2488-97. PubMed ID: 18364399 [Abstract] [Full Text] [Related]
3. Human dental pulp stem cells protect mouse dopaminergic neurons against MPP+ or rotenone. Nesti C, Pardini C, Barachini S, D'Alessandro D, Siciliano G, Murri L, Petrini M, Vaglini F. Brain Res; 2011 Jan 07; 1367():94-102. PubMed ID: 20854799 [Abstract] [Full Text] [Related]
4. Tyrosine hydroxylase-positive amacrine interneurons in the mouse retina are resistant against the application of various parkinsonian toxins. Nagel F, Bähr M, Dietz GP. Brain Res Bull; 2009 Jun 30; 79(5):303-9. PubMed ID: 19406215 [Abstract] [Full Text] [Related]
5. 1-Methyl-4-phenylpyridinium (MPP+) but not 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) selectively destroys dopaminergic neurons in cultures of dissociated rat mesencephalic neurons. Sanchez-Ramos J, Barrett JN, Goldstein M, Weiner WJ, Hefti F. Neurosci Lett; 1986 Dec 12; 72(2):215-20. PubMed ID: 2880321 [Abstract] [Full Text] [Related]
6. FGF-2-mediated protection of cultured mesencephalic dopaminergic neurons against MPTP and MPP+: specificity and impact of culture conditions, non-dopaminergic neurons, and astroglial cells. Otto D, Unsicker K. J Neurosci Res; 1993 Mar 01; 34(4):382-93. PubMed ID: 8097265 [Abstract] [Full Text] [Related]
7. The pesticide rotenone induces caspase-3-mediated apoptosis in ventral mesencephalic dopaminergic neurons. Ahmadi FA, Linseman DA, Grammatopoulos TN, Jones SM, Bouchard RJ, Freed CR, Heidenreich KA, Zawada WM. J Neurochem; 2003 Nov 01; 87(4):914-21. PubMed ID: 14622122 [Abstract] [Full Text] [Related]
8. Effects of creatine treatment on the survival of dopaminergic neurons in cultured fetal ventral mesencephalic tissue. Andres RH, Huber AW, Schlattner U, Pérez-Bouza A, Krebs SH, Seiler RW, Wallimann T, Widmer HR. Neuroscience; 2005 Nov 01; 133(3):701-13. PubMed ID: 15890457 [Abstract] [Full Text] [Related]
9. Granulocyte-colony stimulating factor is neuroprotective in a model of Parkinson's disease. Meuer K, Pitzer C, Teismann P, Krüger C, Göricke B, Laage R, Lingor P, Peters K, Schlachetzki JC, Kobayashi K, Dietz GP, Weber D, Ferger B, Schäbitz WR, Bach A, Schulz JB, Bähr M, Schneider A, Weishaupt JH. J Neurochem; 2006 May 01; 97(3):675-86. PubMed ID: 16573658 [Abstract] [Full Text] [Related]
10. Functional changes in cocultures of mesencephalon and striatal neurons from embryonic C57/BL6 mice due to low concentrations of 1-methyl-4-phenylpyridinium (MPP+). Koutsilieri E, Chan WW, Reinitzer D, Rausch WD. J Neural Transm Gen Sect; 1993 May 01; 94(3):189-97. PubMed ID: 7907217 [Abstract] [Full Text] [Related]
11. The mitochondrial complex I inhibitor annonacin is toxic to mesencephalic dopaminergic neurons by impairment of energy metabolism. Lannuzel A, Michel PP, Höglinger GU, Champy P, Jousset A, Medja F, Lombès A, Darios F, Gleye C, Laurens A, Hocquemiller R, Hirsch EC, Ruberg M. Neuroscience; 2003 May 01; 121(2):287-96. PubMed ID: 14521988 [Abstract] [Full Text] [Related]
13. Pretreatment with near-infrared light via light-emitting diode provides added benefit against rotenone- and MPP+-induced neurotoxicity. Ying R, Liang HL, Whelan HT, Eells JT, Wong-Riley MT. Brain Res; 2008 Dec 03; 1243():167-73. PubMed ID: 18848925 [Abstract] [Full Text] [Related]
14. The selective toxicity of 1-methyl-4-phenylpyridinium to dopaminergic neurons: the role of mitochondrial complex I and reactive oxygen species revisited. Nakamura K, Bindokas VP, Marks JD, Wright DA, Frim DM, Miller RJ, Kang UJ. Mol Pharmacol; 2000 Aug 03; 58(2):271-8. PubMed ID: 10908294 [Abstract] [Full Text] [Related]
15. Neuroprotective effect of rotigotine against complex I inhibitors, MPP⁺ and rotenone, in primary mesencephalic cell culture. Radad K, Scheller D, Rausch WD, Reichmann H, Gille G. Folia Neuropathol; 2014 Aug 03; 52(2):179-86. PubMed ID: 25118903 [Abstract] [Full Text] [Related]
16. Divergent mechanisms of paraquat, MPP+, and rotenone toxicity: oxidation of thioredoxin and caspase-3 activation. Ramachandiran S, Hansen JM, Jones DP, Richardson JR, Miller GW. Toxicol Sci; 2007 Jan 03; 95(1):163-71. PubMed ID: 17018646 [Abstract] [Full Text] [Related]
17. Angiotensin II protects cultured midbrain dopaminergic neurons against rotenone-induced cell death. Grammatopoulos TN, Ahmadi F, Jones SM, Fariss MW, Weyhenmeyer JA, Zawada WM. Brain Res; 2005 May 31; 1045(1-2):64-71. PubMed ID: 15910763 [Abstract] [Full Text] [Related]
18. Granulocyte-macrophage colony-stimulating factor promotes survival of dopaminergic neurons in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced murine Parkinson's disease model. Kim NK, Choi BH, Huang X, Snyder BJ, Bukhari S, Kong TH, Park H, Park HC, Park SR, Ha Y. Eur J Neurosci; 2009 Mar 31; 29(5):891-900. PubMed ID: 19245369 [Abstract] [Full Text] [Related]
20. The rotenone-induced rat model of Parkinson's disease: behavioral and electrophysiological findings. von Wrangel C, Schwabe K, John N, Krauss JK, Alam M. Behav Brain Res; 2015 Feb 15; 279():52-61. PubMed ID: 25446762 [Abstract] [Full Text] [Related] Page: [Next] [New Search]